Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025

Therapeutic modulation to treat blood glucose abnormalities, including type 2 diabetes, and/or reduce HBA1C levels, and associated systems and methods

US Patent 11534611 · Granted Dec 27, 2022

Estimated economic value: $18,757,000

Assignee

Inventors

View full patent text on Google Patents →